Support The Show On Patreon!:

Subscribe to Krystal Kyle & Friends On Substack!:

Vancouver-based MYND Life Sciences is exploring whether depression and other central nervous system disorders can be treated with novel psychedelic drugs, including psilocybin.

In January, the company announced a collaborative research agreement with the University of British Columbia on major depressive disorder.

Follow Kyle on Twitter:

#KyleKulinski #SecularTalk